TRUSCREEN GROUP
TruScreen provides a cancer screening device that resolves many of the ongoing issues associated with traditional methods, such as PAP tests and cytology, including failed samples, poor patient follow up, patient discomfort, and the need for supporting laboratory infrastructure.
TRUSCREEN GROUP
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2013-10-01
Address:
Auckland, Auckland, New Zealand
Country:
New Zealand
Website Url:
http://www.truscreen.com
Total Employee:
1+
Status:
Active
Contact:
+61 (0) 2 9078 7671
Email Addresses:
[email protected]
Technology used in webpage:
Person Schema Gravatar Profiles Fastly Hosted
Similar Organizations
Augusta Laboratory
Augusta Laboratory offers clinical laboratory services.
Cell-Safe Life sciences
Cell-Safe Life sciences offers active implantable immunoisolation device.
Erchonia Corporation
Erchonia Corporation is a medical devices company offering medical and therapeutic devices.
GenesisCrest
GenesisCrest offers medical devices and consulting services.
Medical Device Development Group
Medical Device Development Group offers comprehensive commercialization expertise for medical devices.
Medivative Technologies
Medivative Technologies is a medical devices company offering the medical device.
OmnEcoil Instruments
OmnEcoil Instruments develops a novel device for prostate cancer detection and tissue sampling.
ProVeterináře
ProVeterináře develops surgical instruments and medical devices.
Self-screen
Self-screen focuses on cervical cancer screening and prevention.
Sterionics
Sterionics offers a simple, portable, effective sterilization device.
Stock Details
Official Site Inspections
http://www.truscreen.com Semrush global rank: 7.07 M Semrush visits lastest month: 900
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Truscreen Group"
Home - TruScreen Cervical Cancer Screening Test
Investing in cervical cancer screening and treatment is highly impactful for several reasons: High Burden: Cervical cancer is one of the most common cancers among women, especially in low to middle-income countries where screening …See details»
Company - TruScreen
TruScreen is currently targeting product sales to a range of low and middle-income countries, including China, Mexico, Vietnam, Russia, and Saudi Arabia, where no large-scale cervical …See details»
What We Do - Truescreen
Failure to detect an applicant with hidden problems can create a serious liability for your organization. Efficient screening during the selection stage can support compliance and mitigate risk. Our full suite of services is specifically designed …See details»
Corporate Governance - Truscreen
TruScreen’s Information technology governance falls under three categories which are: Being aware of information and digital technology changes, ensuring the Company has current hardware and software that enables the efficient …See details»
Truscreen Group - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +61 (0) 2 9078 7671 TruScreen provides a cancer screening device that resolves many of the ongoing issues associated with traditional …See details»
About - Truescreen
Truescreen utilizes our considerable industry-specific knowledge and experience to simplify compliance risk into actionable decision points. We provide accurate, reliable data that is relentlessly accountable, helping our clients make safe, …See details»
TruScreen Group Limited - AnnualReports.com
Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and internationally. The company offers the TruScreen …See details»
Truescreen - Crunchbase Company Profile & Funding
A leader in applicant screening. A leader in applicant screening, Truescreen is uniquely qualified to provide a comprehensive suite of services tailored specifically to the needs of global organizations.See details»
TruScreen Group Limited - LinkedIn
We welcome the new CEO, Marty Dillon, who joined TruScreen on 1 March 2024. Marty was the CEO of TruScreen from 2013 to 2019, managing the listing of TruScreen Ltd on the NZX, launching TruScreen ...See details»
TruScreen - YouTube
TruScreen Group Limited (NZX/ASX: TRU) has developed an AI-enabled device that provides real-time, detection of pre-cancerous and cancerous cervical changes to help improve the …See details»
People - TruScreen
Founding CEO: Martin Dillon led TruScreen Group Ltd as its CEO from December 2013 to January 2019. During this tenure, he skillfully managed the listing of TruScreen on the NZAX …See details»
Truescreen - Consumer Care
Truescreen Consumer Care provides support for all your screening needs, including background checks, drug tests, and more.See details»
TruScreen Company Profile - Office Locations, Competitors ... - Craft
Oct 11, 2024 TruScreen $2.11 m in annual revenue in FY 2024. See insights on TruScreen including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Canada - Truescreen
Canada. Truescreen performs thousands of background checks throughout the provinces and territories of Canada every year. Through this experience, we are able to offer our clients …See details»
TruScreen Group Limited (NZE:TRU) (ASX:TRU) - Key Markets Update
Nov 13, 2024 TruScreen Group Limited (NZE:TRU) (ASX:TRU) is a New Zealand-based medical device company that has developed an AI-enabled device that can detect …See details»
TruScreen Cervical Cancer Screening Device Product Details
The TruScreen Cervical Cancer Screening Device. TruScreen is a real-time, objective, AI-enabled screening device. It is CE certified as a primary screening tool. TruScreen screens for the …See details»
Truscreen Commences Major Commercial Rollout in Vietnam
Aug 7, 2024 The purchase and subsequent deployment of our devices will significantly impact the cervical cancer screening landscape in Vietnam. We are confident that TruScreen's …See details»
News - Truscreen
Truscreen Group Limited announced its intention to launch a 1 for 5 pro-rata renounceable rights issue to raise up to circa $2.2 million ("Rights Offer”) on 17 February 2023. The… ViewSee details»
Financial Information - TruScreen
Current Share Price data for TruScreen Group Limited (NZX:TRU ASX:TRU) NZX Listing ASX Listing TruScreen Group Financial Reports. FY25 Half Year Report 30.9.2024. FY25 Half Year …See details»